We recently had the opportunity to interview Dr. Christoph Schmidt, the 2022 Svar Complement Excellence Award Recipient.
Dr. Schmidt is an expert on complement pathways, and his research has revealed incredible new insights that could help design artificial complement regulators. This article explored his work and discussed why his research is so important.
Dr. Schmidt's research focuses on understanding how complement pathways are regulated and how their activity can be manipulated. He has identified novel pathways involved in regulating complement systems and helped develop various strategies for designing artificial complement regulators.
Dr. Schmidt's research is groundbreaking and can potentially positively impact clinical practice. We're excited to see what else he discovers as he continues his work in this field.
We recently had the opportunity to interview Dr. Christoph Schmidt, the 2022 Svar Complement Excellence Award Recipient.
Dr. Schmidt is an expert on complement pathways, and his research has revealed incredible new insights that could help design artificial complement regulators. This article explored his work and discussed why his research is so important.
Dr. Schmidt's research focuses on understanding how complement pathways are regulated and how their activity can be manipulated. He has identified novel pathways involved in regulating complement systems and helped develop various strategies for designing artificial complement regulators.
Dr. Schmidt's research is groundbreaking and can potentially positively impact clinical practice. We're excited to see what else he discovers as he continues his work in this field.
The Svar Complement Excellence Award is distributed annually to individuals who have greatly contributed to the complement field.
The awards are intended as grants for two recipients, each worth €20.000. The awards will be used to support the projects the recipients are working on within the complement field.
The committee consists of members of the International Complement Society (ICS) and the European Complement Network (ECN), as well as last year's awardees and one pharma representative.